Hims & Hers Health Inc
HIMS31.690USD
-2.180-6.44%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
7.21BMarket Cap
52.92P/E TTM
More Details of Hims & Hers Health Inc Company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Hims & Hers Health Inc Info
Ticker SymbolHIMS
Company nameHims & Hers Health Inc
IPO dateSep 09, 2019
CEODudum (Andrew)
Number of employees1637
Security typeOrdinary Share
Fiscal year-endSep 09
Address2269 Chestnut St
CitySAN FRANCISCO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code94123
Phone14158510195
Websitehttps://www.forhims.com/
Ticker SymbolHIMS
IPO dateSep 09, 2019
CEODudum (Andrew)
Company Executives of Hims & Hers Health Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Ms. Andrea Perez
Ms. Andrea Perez
Independent Director
Independent Director
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Mr. Mike Chi
Mr. Mike Chi
Chief Operating Officer
Chief Operating Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.50M
+73709.00%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
171.83K
+18604.00%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
98.05K
-3084.00%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+9935.00%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+6623.00%
Dr. Patrick Carroll, M.D.
Dr. Patrick Carroll, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Online
589.10M
98.35%
Wholesale
9.88M
1.65%
By RegionUSD
Name
Revenue
Proportion
United States
598.98M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Online
589.10M
98.35%
Wholesale
9.88M
1.65%
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Other
61.71%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
10.07%
The Vanguard Group, Inc.
8.88%
Capital World Investors
8.57%
JP Morgan Asset Management
5.87%
Farallon Capital Management, L.L.C.
4.90%
Other
61.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.26%
Investment Advisor/Hedge Fund
13.37%
Research Firm
12.70%
Hedge Fund
10.85%
Individual Investor
6.37%
Pension Fund
1.81%
Bank and Trust
1.46%
Sovereign Wealth Fund
0.74%
Private Equity
0.23%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1031
207.42M
94.59%
-8.21M
2025Q3
970
195.39M
89.11%
-889.66K
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
22.09M
10.07%
+414.70K
+1.91%
Sep 30, 2025
The Vanguard Group, Inc.
19.47M
8.88%
+841.15K
+4.51%
Sep 30, 2025
Capital World Investors
18.78M
8.57%
+223.89K
+1.21%
Sep 30, 2025
JP Morgan Asset Management
12.87M
5.87%
+12.26M
+2026.69%
Sep 30, 2025
Farallon Capital Management, L.L.C.
10.75M
4.9%
+2.53M
+30.84%
Sep 30, 2025
Dudum (Andrew)
9.50M
4.33%
+73.71K
+0.78%
Dec 15, 2025
Renaissance Technologies LLC
9.10M
4.15%
+2.23M
+32.42%
Sep 30, 2025
Goldman Sachs & Company, Inc.
8.54M
3.9%
+998.73K
+13.24%
Sep 30, 2025
State Street Investment Management (US)
7.17M
3.27%
+132.38K
+1.88%
Sep 30, 2025
Morgan Stanley & Co. LLC
5.93M
2.71%
+1.88M
+46.43%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
3.83%
Global X HealthTech ETF
3.75%
Amplify Weight Loss Drug & Treatment ETF
3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
3.66%
YieldMax Ultra Option Income Strategy ETF
2.96%
Invesco S&P MidCap 400 Pure Growth ETF
2.4%
State Street SPDR S&P Health Care Services ETF
1.94%
Amplify Online Retail ETF
1.85%
Invesco S&P MidCap 400 GARP ETF
1.65%
VanEck Social Sentiment ETF
1.53%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion3.83%
Global X HealthTech ETF
Proportion3.75%
Amplify Weight Loss Drug & Treatment ETF
Proportion3.67%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion3.66%
YieldMax Ultra Option Income Strategy ETF
Proportion2.96%
Invesco S&P MidCap 400 Pure Growth ETF
Proportion2.4%
State Street SPDR S&P Health Care Services ETF
Proportion1.94%
Amplify Online Retail ETF
Proportion1.85%
Invesco S&P MidCap 400 GARP ETF
Proportion1.65%
VanEck Social Sentiment ETF
Proportion1.53%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Hims & Hers Health Inc?
The top five shareholders of Hims & Hers Health Inc are:
BlackRock Institutional Trust Company, N.A. holds 22.09M shares, accounting for 10.07% of the total shares.
The Vanguard Group, Inc. holds 19.47M shares, accounting for 8.88% of the total shares.
Capital World Investors holds 18.78M shares, accounting for 8.57% of the total shares.
JP Morgan Asset Management holds 12.87M shares, accounting for 5.87% of the total shares.
Farallon Capital Management, L.L.C. holds 10.75M shares, accounting for 4.90% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 22.09M shares, accounting for 10.07% of the total shares.
The Vanguard Group, Inc. holds 19.47M shares, accounting for 8.88% of the total shares.
Capital World Investors holds 18.78M shares, accounting for 8.57% of the total shares.
JP Morgan Asset Management holds 12.87M shares, accounting for 5.87% of the total shares.
Farallon Capital Management, L.L.C. holds 10.75M shares, accounting for 4.90% of the total shares.
What are the top three shareholder types of Hims & Hers Health Inc?
The top three shareholder types of Hims & Hers Health Inc are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
How many institutions hold shares of Hims & Hers Health Inc (HIMS)?
As of 2025Q4, 1031 institutions hold shares of Hims & Hers Health Inc, with a combined market value of approximately 207.42M, accounting for 94.59% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 5.48%.
What is the biggest source of revenue for Hims & Hers Health Inc?
In FY2025Q3, the Online business generated the highest revenue for Hims & Hers Health Inc, amounting to 589.10M and accounting for 98.35% of total revenue.
